Local Partner & Co-Host

The SIB Swiss Institute of Bioinformatics fosters excellence in data science to support progress in biological research and health.

Local Partner & Co-Host

ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publicly funded research. It coordinates, integrates and sustains bioinformatics resources across its member states and enables users in academia and industry to access services that are vital for their research.

Amazon Web Services (AWS) is a secure cloud services platform, offering compute power, database storage, content delivery and other functionality to help businesses scale and grow. Explore how millions of customers are currently leveraging AWS cloud products and solutions to build sophisticated applications with increased flexibility, scalability and reliability.

Google Cloud is widely recognized as a global leader in delivering a secure, open, intelligent, and transformative enterprise cloud platform. Their technology is built on Google’s private network and is the product of nearly 20 years of innovation in security, network architecture, collaboration, artificial intelligence, and open source software. They offer a simply engineered set of tools and unparalleled technology across Google Cloud Platform and G Suite that help bring people, insights, and ideas together.

Abbvie has 29,000 scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. They come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.
AbbVie targets specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. It's constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.

The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for health research. Composed of 13 Institutes, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

With a population of about 198,000, the city of Basel is the canton’s social, economic, political and cultural centre. Located on the border triangle between Switzerland, France and Germany, the cultural openness of the city is a boon for the entire canton. More than any other Swiss canton, the diminutive metropolitan city of Basel successfully blends tradition and modernity.

Illumina provides sequencing and array-based solutions for analysis of genetic variation and function, in fields ranging from cancer research to agriculture.

The Japan Agency for Medical Research and Development (AMED) was established on April 1, 2015, for the purpose of improving medicine through research and development in Japan and with the goal to fast-track medical R&D that directly benefits people, not only by extending life spans, but also by improving quality of life. AMED engages in research and development in the field of medicine, establishes and maintains an environment for medical R&D, and provides funding, in order to promote integrated medical R&D.

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres, with additional sites in Cambridge, UK and South San Francisco, CA.

PHRT stands for Personalized Health and Related Technologies, and is a Strategic Focus Area of the ETH Domain. The initiative encompasses core contributions from the institutions of the ETH Domain that are complementary to the efforts undertaken by other initiatives, such as the Swiss Personalized Health Network (SPHN) and international programs.

Mandated by the federal government, the Swiss National Science Foundation (SNSF) supports basic science in all academic disciplines, from history to medicine and the engineering sciences. The SNSF is Switzerland’s foremost research funding organisation and supports approximately 8,500 researchers every year.

The Swiss Personalized Health Network (SPHN) is a national initiative designed to promote the development of personalized medicine and personalized health in Switzerland.

The University of Zurich is one of the leading research universities in Europe and offers the widest range of degree programs in Switzerland.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.